Tag: EpiVax Inc.
Five Questions With: Dr. Anne S. De Groot
Dr. Anne S. De Groot is the CEO and chief science officer of Providence-based vaccinology and immunology company EpiVax Inc., which last month celebrated its 25th anniversary.
PBN: What...
EpiVax, Greenlight partner to produce mRNA cancer treatments
PROVIDENCE – Technology developed by EpiVax Therapeutics Inc. will power a new effort to produce individualized, mRNA vaccine-based cancer treatments in a partnership with...
Survey: Local nonprofits struggling with financial, staffing woes
PROVIDENCE – A survey conducted by the United Way of Rhode Island and the Grantmakers Council of Rhode Island paints a bleak picture for...
EpiVax partners with Dutch company to produce universal coronavirus vaccine
PROVIDENCE – EpiVax Inc. is partnering with Intravacc to develop a universal vaccine for betacoronaviruses, including SARS-CoV-2.
The project is funded by the Coalition for...
R.I. escalates efforts to contain monkeypox
Treating a cough or sore throat used to be a lot simpler. But since the COVID-19 outbreak more than two years ago, common symptoms...
Dr. Anne S. De Groot
SEEING BEYOND THE HORIZON has been a hallmark of EpiVax Inc. founder, CEO and Chief Science Officer Dr. Anne S. De Groot since she...
R.I. plays role in making new COVID-19 vaccines
What seemed like an epic race for an effective COVID-19 vaccine has produced several options that have people rolling up their sleeves across Rhode...
FDA awards EpiVax $1.1 million research contract
PROVIDENCE – Biotechnology company EpiVax Inc. received $1.1 million in funding Wednesday from the U.S. Food and Drug Administration to further research efforts in...
Manufacturers, nonprofits, tech companies among honored in PBN’s 2020 Fastest Growing...
PROVIDENCE – Thirty-three companies were honored Wednesday by Providence Business News for their revenue growth and company innovation in the publication’s 2020 Fastest Growing...
EpiVax’s mission revolves around a culture of curiosity
PBN FASTEST GROWING COMPANIES 2020 $5M - $25M
5. EpiVax Inc.
CEO (or equivalent): Dr. Anne De Groot, CEO and chief scientific officer
2019 Revenue: $6.8 million
2017...
- Featured Event -
